Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Experts Discuss the Quandary of Whether to Discontinue or Taper Treatment and When
-
- Top Five Stories for World Autoimmune Arthritis Day
- Anti-tumor Necrosis and Inflammatory Bowel Disease Edouard Louis, MD, PhD
- FDA Accepts Review of Supplemental New Drug Applications of Xeljanz, Xeljanz XR for Psoriatic Arthritis
- FDA Approves Actemra for Giant Cell Arteritis
- FDA Approves Kevzara for Rheumatoid Arthritis
- Should I Stay or Should I Go? Leonard H. Calabrese, DO
- Unspoken and Undiagnosed: Addressing Sex and Intimacy Issues in Rheumatic Disease
- Psoriatic Arthritis Linked With Diabetes, Other Endocrine Disorders
-
- Study: RA-attributed Deaths Declined From 1987 to 2011
- Interferon-alpha Led to Remission in Patients With Eosinophilic Granulomatosis With Polyangiitis
- Certolizumab Pegol Shows Long-term Safety in Treating RA
- EHR Algorithms Help Researchers Identify Patients With Lupus
- VIDEO: Association Exists Between Osteoarthritis, Gout
- Exercise Protocol Associated With Improved Physical Function in Patients With Hip, Knee OA
- Exercise Program Participation Linked With Reduced Pain in Patients With Knee OA
- Real-world Studies Support the Use of Infliximab Biosimilars
-
- Researchers Find Link Between Gut Microbiome, Osteoarthritis Pain
- Speaker: Drug Development for Lupus Presents Opportunity, Reason for Optimism
- VIDEO: How to Optimize Outcomes for Patients With ANCA-associated Vasculitis
- VIDEO: Lohmander Calls for Individualized Exercise Therapy for Patients With OA
- Patients With Lupus Without History of Kidney Disease Rarely Got Kidney Disease During Pregnancy
- Survey: Most Patients With RA Reported Having Pain Daily or Multiple Times Per Week, Despite Treatment
- Meta-analysis Indicates NSAIDs Linked with Increased Risk for Heart Attack